Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

465 ARTÍCULOS , VIENDO DEL 391 AL 405

Role of cholesterol in APP metabolism and its significance in Alzheimer's disease pathogenesis

Maulik M, Westaway D, Jhamandas JH, Kar S.

Mol Neurobiol. 2013 Feb;47(1):37-63. doi: 10.1007/s12035-012-8337-y. Epub 2012 Sep 16.

Oral reading fluency analysis in patients with Alzheimer disease and asymptomatic control subjects

Martínez-Sánchez F, Meilán JJ, García-Sevilla J, Carro J, Arana JM.

Neurologia. 2013 Jul-Aug;28(6):325-31. doi: 10.1016/j.nrl.2012.07.012. Epub 2012 Oct 6.

Non-coding RNAs in Alzheimer's disease

Tan L, Yu JT, Hu N, Tan L.

Mol Neurobiol. 2013 Feb;47(1):382-93. doi: 10.1007/s12035-012-8359-5. Epub 2012 Oct 7.

Default network is not hypoactive in dementia with fluctuating cognition: an Alzheimer disease/dementia with Lewy bodies comparison

Franciotti R, Falasca NW, Bonanni L, Anzellotti F, Maruotti V, Comani S, Thomas A, Tartaro A, Taylor JP, Onofrj M.

Neurobiol Aging. 2013 Apr;34(4):1148-58. doi: 10.1016/j.neurobiolaging.2012.09.015. Epub 2012 Oct 11.

CYP46A1 T/C polymorphism associated with the APOE ε4 allele increases the risk of Alzheimer's disease

Li L, Yin Z, Liu J, Li G, Wang Y, Yan J, Zhou H.

J Neurol. 2013 Jul;260(7):1701-8. doi: 10.1007/s00415-012-6690-4. Epub 2012 Oct 16.

Genetic polymorphism of interleukin 1β -511C/T and susceptibility to sporadic Alzheimer's disease: a meta-analysis

Yuan H, Xia Q, Ge P, Wu S.

Mol Biol Rep. 2013 Feb;40(2):1827-34. doi: 10.1007/s11033-012-2237-0. Epub 2012 Oct 19.

Brain ischemia activates β- and γ-secretase cleavage of amyloid precursor protein: significance in sporadic Alzheimer's disease

Pluta R, Furmaga-Jabłońska W, Maciejewski R, Ułamek-Kozioł M, Jabłoński M.

Mol Neurobiol. 2013 Feb;47(1):425-34. doi: 10.1007/s12035-012-8360-z. Epub 2012 Oct 19.

The capillary dysfunction hypothesis of Alzheimer's disease

Østergaard L, Aamand R, Gutiérrez-Jiménez E, Ho YC, Blicher JU, Madsen SM, Nagenthiraja K, Dalby RB, Drasbek KR, Møller A, Brændgaard H, Mouridsen K, Jespersen SN, Jensen MS, West MJ.

Neurobiol Aging. 2013 Apr;34(4):1018-31. doi: 10.1016/j.neurobiolaging.2012.09.011. Epub 2012 Oct 18.

Astrocyte signaling and neurodegeneration: new insights into CNS disorders

Brambilla L, Martorana F, Rossi D.

Prion. 2013 Jan-Feb;7(1):28-36. doi: 10.4161/pri.22512. Epub 2012 Oct 23.

Alzheimer's disease: an update of the roles of receptors, astrocytes and primary cilia (review)

Armato U, Chakravarthy B, Pacchiana R, Whitfield JF.

Int J Mol Med. 2013 Jan;31(1):3-10. doi: 10.3892/ijmm.2012.1162. Epub 2012 Oct 24.

A direct morphometric comparison of five labeling protocols for multi-atlas driven automatic segmentation of the hippocampus in Alzheimer's disease

Nestor SM, Gibson E, Gao FQ, Kiss A, Black SE; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2013 Feb 1;66:50-70. doi: 10.1016/j.neuroimage.2012.10.081. Epub 2012 Nov 7.

A non-transgenic mouse model (icv-STZ mouse) of Alzheimer's disease: similarities to and differences from the transgenic model (3xTg-AD mouse)

Chen Y, Liang Z, Blanchard J, Dai CL, Sun S, Lee MH, Grundke-Iqbal I, Iqbal K, Liu F, Gong CX.

Mol Neurobiol. 2013 Apr;47(2):711-25. doi: 10.1007/s12035-012-8375-5. Epub 2012 Nov 14.

Variant TREM2 as risk factor for Alzheimer's disease

Neumann H, Daly MJ.

N Engl J Med. 2013 Jan 10;368(2):182-4. doi: 10.1056/NEJMe1213157. Epub 2012 Nov 14.

Intracerebral propagation of Alzheimer's disease: strengthening evidence of a herpes simplex virus etiology

Ball MJ, Lukiw WJ, Kammerman EM, Hill JM.

Alzheimers Dement. 2013 Mar;9(2):169-75. doi: 10.1016/j.jalz.2012.07.005. Epub 2012 Nov 14.

APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease

Wolf AB, Caselli RJ, Reiman EM, Valla J.

Neurobiol Aging. 2013 Apr;34(4):1007-17. doi: 10.1016/j.neurobiolaging.2012.10.011. Epub 2012 Nov 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias